Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01250561 · ClinicalTrials.gov registry record · NA
Reduction of Postherpetic Neuralgia in Herpes Zoster
A NA study, sponsored by Center for Clinical Studies, Texas.
- Completed
- Registry status
- NA
- Development phase
- 133
- Enrollment target
NCT01250561: Completed NA study, sponsored by Center for Clinical Studies, Texas.
NCT01250561 is a NA study that has completed, run by Center for Clinical Studies, Texas. The registered enrollment target is 133 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01250561, a NA study, has completed, sponsored by Center for Clinical Studies, Texas.
- COMPLETED
- Registry status
- NA
- Development phase
- 133 participants
- Enrollment target
Study Summary
The addition of gabapentin therapy to standard antiviral treatment with valacyclovir in acute herpes zoster patients will decrease the incidence of post-herpetic neuralgia.
Interventions
- DRUG Valacyclovir
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2002-02 |
| Est. Completion | 2007-10 |
| Phase | NA |
What the finished NCT01250561 record still lists
NCT01250561 is an interventional study that assigns participants to a tested intervention. The registered 133 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Valacyclovir is the first listed.
NCT01250561 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01250561 about?
NCT01250561 is a clinical study titled "Reduction of Postherpetic Neuralgia in Herpes Zoster". The addition of gabapentin therapy to standard antiviral treatment with valacyclovir in acute herpes zoster patients will decrease the incidence of post-herpetic neuralgia.
What is the current status of trial NCT01250561?
This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2002-02. Estimated completion is 2007-10.
What interventions are being tested in trial NCT01250561?
The interventions under investigation include: Valacyclovir (DRUG), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT01250561?
This trial is sponsored by Center for Clinical Studies, Texas, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01250561's enrollment target sits among peer trials
133 729th of 2000 higher than 1,272 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276870 · 133 participants · Phase 2
Orphan Indications for CD19 Redirected Autologous T Cells
- NCT04671771 · 133 participants · NA
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- NCT05610085 · 133 participants · Phase 2
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
- NCT06206486 · 133 participants
The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia